SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc.(SAGE) Shareholders - The Eastern Progress Online
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Jacobs Levy Equity Management Inc. Has $9.10 Million Stock Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat
Jacobs Levy Equity Management Inc. Reduces Stake in Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
RTW Investments LP Boosts Stock Position in Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat

Pages